Vor Biopharma Inc (VOR)

Vor Biopharma Inc (VOR) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.2B; returns 1 day -3.6%, 1 week +1.3%, 1 year -34.2%.

VOR Biopharma Inc. is a clinical-stage biotechnology company primarily focused on developing novel therapies for autoimmune diseases. As of early 2026, the company's core asset is telitacicept, a dual BAFF/APRIL inhibitor designed to rebalance the immune system by reducing autoreactive B cells and autoantibody production, which are critical drivers of autoimmune pathology.

Groups VOR belongs to

• Biotechnology
• Clinical Stage Biotech
• Autoimmune Diseases
• Healthcare
• Clinical Stage
• Biopharmaceutical
• Strategic Pivot
• Life Sciences

VOR financial model: income statement, cash flow and balance sheet